 | Proteon Therapeutics (NASDAQ:PRTO) Stock Passes Below Fifty Day Moving Average of $19.53
americanbankingnews.com - January 21 at 4:34 AM |
| Proteon Therapeutics (NASDAQ:PRTO) Hits New 52-Week High at $25.20
americanbankingnews.com - January 4 at 7:46 PM |
 | DuPont Animal Nutrition to Partner with Proteon Pharmaceuticals in the Poultry Industry
finance.yahoo.com - September 9 at 12:49 PM |
 | Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina Tru
www.bloomberg.com - December 10 at 11:59 PM |
| Hedge Funds Watching Proteon Therapeutics Inc (PRTO) From Afar
finance.yahoo.com - November 30 at 12:00 AM |
| Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), and
www.bloomberg.com - November 24 at 6:15 AM |
| SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.
finance.yahoo.com - November 21 at 5:47 PM |
| Proteon Therapeutics Inc
www.bloomberg.com - October 31 at 10:31 PM |
 | BRIEF-Proteon Therapeutics Posts Q3 $1.5 Million
www.msn.com - October 31 at 10:31 PM |
| Proteon Therapeutics Announces Third Quarter 2019 Financial Results
finance.yahoo.com - October 31 at 5:31 PM |
|
| Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – DOVA, VSI, PRTO
finance.yahoo.com - October 22 at 6:56 PM |
| SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - PRTO, ROAN, PGNX
finance.yahoo.com - October 18 at 1:49 PM |
| SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Proteon Therapeutics, Inc. (NASDAQ CM: PRTO)
finance.yahoo.com - October 18 at 8:49 AM |
| PROTEON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteon Therapeutics, Inc. - PRTO
finance.yahoo.com - October 3 at 9:44 PM |
| HLND, UCFC, and TRCB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
finance.yahoo.com - September 26 at 3:33 PM |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Proteon Therapeutics, Inc. with ArTara Therapeutics, Inc. is Fair to PRTO Shareholders
finance.yahoo.com - September 25 at 8:33 PM |
| Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Proteon Therapeutics, Inc. (NASDAQ: PRTO) on Behalf of Proteon Shareholders and Encourages Proteon Investors to Contact the Firm
finance.yahoo.com - September 25 at 3:32 PM |
| PRTO, ARTX Shareholder Investigation: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders – PRTO, ARTX
finance.yahoo.com - September 24 at 5:15 PM |
| PROTEON THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger
finance.yahoo.com - September 24 at 5:15 PM |
| BRIEF-Proteon Therapeutics And Artara Therapeutics Agree To Combine
www.msn.com - September 23 at 8:55 PM |
 | Proteon and ArTara to merge
seekingalpha.com - September 23 at 8:55 PM |
| BRIEF-Proteon Therapeutics Reports Qtrly Net Loss Per Share $0.27
www.msn.com - August 8 at 12:20 AM |
| Proteon Therapeutics EPS misses by $0.14
seekingalpha.com - August 7 at 8:43 AM |
| Proteon Therapeutics Announces Second Quarter 2019 Financial Results
finance.yahoo.com - August 7 at 8:43 AM |
| Those Who Purchased Proteon Therapeutics (NASDAQ:PRTO) Shares Three Years Ago Have A 95% Loss To Show For It
finance.yahoo.com - July 11 at 5:30 PM |
 | Once fast-rising KC company explores sale after second drug trial failure
www.bizjournals.com - April 25 at 6:25 PM |
| Proteon exploring sale after 2nd drug trial failure
finance.yahoo.com - April 19 at 6:15 PM |
| Proteon to explore strategic alternatives; shares up 8% after hours
seekingalpha.com - April 15 at 6:34 PM |
|
| Proteon Therapeutics Announces Review of Potential Strategic Transactions
finance.yahoo.com - April 15 at 6:34 PM |
 | Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?
247wallst.com - March 28 at 6:28 PM |
| Proteon's vonapanitase flunks second late-stage study
seekingalpha.com - March 28 at 9:31 AM |
| Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
finance.yahoo.com - March 28 at 9:31 AM |
| Proteon files for stock offering; shares down 4% after hours
seekingalpha.com - March 15 at 9:36 AM |
| Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - March 13 at 11:17 AM |
| Proteon Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 13 at 11:17 AM |
 | Proteon Therapeutics Inc.
www.barrons.com - March 6 at 6:40 PM |
| Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
finance.yahoo.com - March 4 at 6:51 PM |
| Proteon down 3%
seekingalpha.com - January 24 at 5:45 PM |
 | Results supported the design of ongoing pivotal study and FDA Breakthrough Therapy designation
globenewswire.com - January 24 at 9:20 AM |
| Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
finance.yahoo.com - January 24 at 9:20 AM |
| Does The Proteon Therapeutics, Inc. (NASDAQ:PRTO) Share Price Fall With The Market?
finance.yahoo.com - December 20 at 4:58 PM |
